As of today (2024-06-21), Medeon Biodesign's share price is NT$49.90.
Medeon Biodesign's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was NT$-6.97. Hence, Medeon Biodesign's Price-to-Free-Cash-Flow Ratio for today is N/A.
The historical rank and industry rank for Medeon Biodesign's Price-to-Free-Cash-Flow or its related term are showing as below:
During the past 12 years, Medeon Biodesign's highest Price-to-Free-Cash-Flow Ratio was 163.50. The lowest was 16.81. And the median was 54.30.
ROCO:6499's Price-to-Free-Cash-Flow is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 32.51 * Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was -26.90% per year.
During the past 12 years, Medeon Biodesign's highest 3-Year average Free Cash Flow per Share Growth Rate was 31.50% per year. The lowest was -61.90% per year. And the median was -2.50% per year.
Medeon Biodesign Price-to-Free-Cash-Flow Historical Data
The historical data trend for Medeon Biodesign's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Medeon Biodesign's Price-to-Free-Cash-Flow
For the Medical Instruments & Supplies subindustry, Medeon Biodesign's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medeon Biodesign's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medeon Biodesign's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Medeon Biodesign's Price-to-Free-Cash-Flow falls into.
Medeon Biodesign's Share Price of today is NT$49.90. Medeon Biodesign's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-6.97.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Medeon Biodesign Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Medeon Biodesign's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Medeon Biodesign Inc develops medical device products. The main services of the Group are the research and development of medical devices, manufacturing, and sale of injection molding and components of medical devices. The company provides products in the fields of cardiovascular and laparoscopic. Its business includes Medical Device Development Department and Medical Device Components Manufacturing and Sales Department. The majority of the company revenue comes from Medical Device Components Manufacturing and Sales Department segment. The company revenue is mainly derived from the USA.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ROCO:6499 has been successfully added to your 